These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25187353)

  • 1. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
    Goldstein JI; Jarskog LF; Hilliard C; Alfirevic A; Duncan L; Fourches D; Huang H; Lek M; Neale BM; Ripke S; Shianna K; Szatkiewicz JP; Tropsha A; van den Oord EJ; Cascorbi I; Dettling M; Gazit E; Goff DC; Holden AL; Kelly DL; Malhotra AK; Nielsen J; Pirmohamed M; Rujescu D; Werge T; Levy DL; Josiassen RC; Kennedy JL; Lieberman JA; Daly MJ; Sullivan PF
    Nat Commun; 2014 Sep; 5():4757. PubMed ID: 25187353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
    Girardin FR; Poncet A; Perrier A; Vernaz N; Pletscher M; F Samer C; Lieberman JA; Villard J
    Pharmacogenomics J; 2019 Apr; 19(2):211-218. PubMed ID: 29298994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK; Need AC; Lohoff FW; Zai CC; Chowdhury NI; Müller DJ; Putkonen A; Repo-Tiihonen E; Hallikainen T; Yağcıoğlu AE; Tiihonen J; Kennedy JL; Meltzer HY
    Mol Psychiatry; 2014 Apr; 19(4):403-5. PubMed ID: 23752246
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population.
    Saito T; Ikeda M; Mushiroda T; Ozeki T; Kondo K; Shimasaki A; Kawase K; Hashimoto S; Yamamori H; Yasuda Y; Fujimoto M; Ohi K; Takeda M; Kamatani Y; Numata S; Ohmori T; Ueno S; Makinodan M; Nishihata Y; Kubota M; Kimura T; Kanahara N; Hashimoto N; Fujita K; Nemoto K; Fukao T; Suwa T; Noda T; Yada Y; Takaki M; Kida N; Otsuru T; Murakami M; Takahashi A; Kubo M; Hashimoto R; Iwata N
    Biol Psychiatry; 2016 Oct; 80(8):636-42. PubMed ID: 26876947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C; Guirgis H; Votolato N
    Am J Psychiatry; 2011 Oct; 168(10):1120. PubMed ID: 21969051
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
    Legge SE; Walters JT
    Pharmacogenomics; 2019 Mar; 20(4):279-290. PubMed ID: 30767710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.
    Dettling M; Cascorbi I; Opgen-Rhein C; Schaub R
    Pharmacogenomics J; 2007 Oct; 7(5):325-32. PubMed ID: 17001352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
    Wadelius M; Eriksson N; Kreutz R; Bondon-Guitton E; Ibañez L; Carvajal A; Lucena MI; Sancho Ponce E; Molokhia M; Martin J; Axelsson T; Kohnke H; Yue QY; Magnusson PKE; Bengtsson M; Hallberg P;
    Clin Pharmacol Ther; 2018 May; 103(5):843-853. PubMed ID: 28762467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.
    Valevski A; Klein T; Gazit E; Meged S; Stein D; Elizur A; Narinsky ER; Kutzuk D; Weizman A
    Eur J Immunogenet; 1998 Feb; 25(1):11-3. PubMed ID: 9587740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC; Dettling M; Cascorbi I; Mosyagin I; Salisbury BA; Pierz KA; Zou W; Whalen H; Malhotra AK; Lencz T; Gerson SL; Kane JM; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Legge SE; Hamshere ML; Ripke S; Pardinas AF; Goldstein JI; Rees E; Richards AL; Leonenko G; Jorskog LF; ; Chambert KD; Collier DA; Genovese G; Giegling I; Holmans P; Jonasdottir A; Kirov G; McCarroll SA; MacCabe JH; Mantripragada K; Moran JL; Neale BM; Stefansson H; Rujescu D; Daly MJ; Sullivan PF; Owen MJ; O'Donovan MC; Walters JTR
    Mol Psychiatry; 2017 Oct; 22(10):1502-1508. PubMed ID: 27400856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.
    Dettling M; Schaub RT; Mueller-Oerlinghausen B; Roots I; Cascorbi I
    Pharmacogenetics; 2001 Mar; 11(2):135-41. PubMed ID: 11266078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-induced agranulocytosis/granulocytopenia: mechanisms and monitoring.
    Wiciński M; Węclewicz MM
    Curr Opin Hematol; 2018 Jan; 25(1):22-28. PubMed ID: 28984748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry.
    Konte B; Walters JTR; Rujescu D; Legge SE; Pardiñas AF; Cohen D; Pirmohamed M; Tiihonen J; Hartmann AM; Bogers JP; van der Weide J; van der Weide K; Putkonen A; Repo-Tiihonen E; Hallikainen T; Silva E; Ingimarsson O; Sigurdsson E; Kennedy JL; Sullivan PF; Rietschel M; Breen G; Stefansson H; Stefansson K; Collier DA; O'Donovan MC; Giegling I
    Transl Psychiatry; 2021 Apr; 11(1):214. PubMed ID: 33846298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA associations in clozapine-induced agranulocytosis.
    Yunis JJ; Corzo D; Salazar M; Lieberman JA; Howard A; Yunis EJ
    Blood; 1995 Aug; 86(3):1177-83. PubMed ID: 7620171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach.
    Regen F; Herzog I; Hahn E; Ruehl C; Le Bret N; Dettling M; Heuser I; Hellmann-Regen J
    Toxicol Appl Pharmacol; 2017 Feb; 316():10-16. PubMed ID: 27939987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of antipsychotic-induced side effects and agranulocytosis.
    Chowdhury NI; Remington G; Kennedy JL
    Curr Psychiatry Rep; 2011 Apr; 13(2):156-65. PubMed ID: 21336863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.
    Lahdelma L; Ahokas A; Andersson LC; Suvisaari J; Hovatta I; Huttunen MO; Koskimies S
    J Clin Psychopharmacol; 2001 Feb; 21(1):4-7. PubMed ID: 11199946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis.
    Corzo D; Yunis JJ; Yunis EJ; Howard A; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():149-52. PubMed ID: 7961560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis.
    Claas FH; Abbott PA; Witvliet MD; D'Amaro J; Barnes PM; Krupp P
    Drug Saf; 1992; 7 Suppl 1():3-6. PubMed ID: 1503675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.